Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. SC 13D Stake Beneficial Ownership Report
  2. SC 13D Stake Beneficial Ownership Report
  3. SC 13D Stake Beneficial Ownership Report
  4. SC 13D Stake Beneficial Ownership Report
  5. SC 13D Stake Beneficial Ownership Report
  6. SC 13D Stake Beneficial Ownership Report
  7. S-1 Offering Registration Statement
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. D Other Notice of Sales of Unregistered Securities
  12. 8-K Event Material agreement · Unregistered share sale
  13. 8-K Event Auditor change
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. D Other Notice of Sales of Unregistered Securities
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 50 of 72 · 1,429 filings